Medical Care
Global cGMP Lentivirus Production Market Research Report 2025
- May 12, 25
- ID: 237389
- Pages: 132
- Figures: 131
- Views: 14
The global market for cGMP Lentivirus Production was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lentiviruses are a subclass of retroviruses, but unlike other retroviruses, lentiviruses can integrate into the genome of non-dividing cells. As retroviral vectors, lentiviral vectors never contain genes for replication. Therefore, production of lentivirus requires propagation in packaging cell lines (e.g., HEK293 cells transfected with plasmids encoding virion proteins). The Lentiviral Production System is an early optimized system that provides a scalable, high-throughput lentiviral vector production platform. Compared with retroviral vectors produced in stable cell lines, clinical-grade lentiviruses are mostly produced by transient transfection of 293 or 293T cells in cell factories. However, recent advances have favored the use of hollow fiber tube reactors, suspension culture, and improved stable cell line production.
North American market for cGMP Lentivirus Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for cGMP Lentivirus Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for cGMP Lentivirus Production in CDMO is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of cGMP Lentivirus Production include Thermo Fisher Scientific, Oxgene, Lonza, Charles River (Vigene Biosciences), Merck, Cytiva, Oxford Biomedica, AGC Biologics(MolMed), GeneMedi, OriGene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for cGMP Lentivirus Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cGMP Lentivirus Production.
The cGMP Lentivirus Production market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global cGMP Lentivirus Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the cGMP Lentivirus Production companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Oxgene
Lonza
Charles River (Vigene Biosciences)
Merck
Cytiva
Oxford Biomedica
AGC Biologics(MolMed)
GeneMedi
OriGene
Invitria
Polyplus (Sartorius)
Kerafast
CCRM
SignaGen Laboratories
Cellomics Technology
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Gene Universal
Aldevron
Takara Bio
Gentarget
Bluebird Bio
ElevateBio
Genezen
EurekaBio
Obio Technology
WuXi ATU
GenScript ProBio
Creative Biogene
VIVEbiotech
Yposkesi (SK pharmteco)
VectorBuilder
Esco Aster
Andelyn Biosciences
Single Use Support
Segment by Type
Adherent Culture
Suspension Culture
Others
Segment by Application
CDMO
Biotech
Pharma
Academia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cGMP Lentivirus Production company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lentiviruses are a subclass of retroviruses, but unlike other retroviruses, lentiviruses can integrate into the genome of non-dividing cells. As retroviral vectors, lentiviral vectors never contain genes for replication. Therefore, production of lentivirus requires propagation in packaging cell lines (e.g., HEK293 cells transfected with plasmids encoding virion proteins). The Lentiviral Production System is an early optimized system that provides a scalable, high-throughput lentiviral vector production platform. Compared with retroviral vectors produced in stable cell lines, clinical-grade lentiviruses are mostly produced by transient transfection of 293 or 293T cells in cell factories. However, recent advances have favored the use of hollow fiber tube reactors, suspension culture, and improved stable cell line production.
North American market for cGMP Lentivirus Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for cGMP Lentivirus Production is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for cGMP Lentivirus Production in CDMO is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of cGMP Lentivirus Production include Thermo Fisher Scientific, Oxgene, Lonza, Charles River (Vigene Biosciences), Merck, Cytiva, Oxford Biomedica, AGC Biologics(MolMed), GeneMedi, OriGene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for cGMP Lentivirus Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cGMP Lentivirus Production.
The cGMP Lentivirus Production market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global cGMP Lentivirus Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the cGMP Lentivirus Production companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Oxgene
Lonza
Charles River (Vigene Biosciences)
Merck
Cytiva
Oxford Biomedica
AGC Biologics(MolMed)
GeneMedi
OriGene
Invitria
Polyplus (Sartorius)
Kerafast
CCRM
SignaGen Laboratories
Cellomics Technology
FUJIFILM Diosynth Biotechnologies
Biovian
Miltenyi Bioindustry
Gene Universal
Aldevron
Takara Bio
Gentarget
Bluebird Bio
ElevateBio
Genezen
EurekaBio
Obio Technology
WuXi ATU
GenScript ProBio
Creative Biogene
VIVEbiotech
Yposkesi (SK pharmteco)
VectorBuilder
Esco Aster
Andelyn Biosciences
Single Use Support
Segment by Type
Adherent Culture
Suspension Culture
Others
Segment by Application
CDMO
Biotech
Pharma
Academia
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cGMP Lentivirus Production company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global cGMP Lentivirus Production Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adherent Culture
1.2.3 Suspension Culture
1.2.4 Others
1.3 Market by Application
1.3.1 Global cGMP Lentivirus Production Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 CDMO
1.3.3 Biotech
1.3.4 Pharma
1.3.5 Academia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global cGMP Lentivirus Production Market Perspective (2020-2031)
2.2 Global cGMP Lentivirus Production Growth Trends by Region
2.2.1 Global cGMP Lentivirus Production Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 cGMP Lentivirus Production Historic Market Size by Region (2020-2025)
2.2.3 cGMP Lentivirus Production Forecasted Market Size by Region (2026-2031)
2.3 cGMP Lentivirus Production Market Dynamics
2.3.1 cGMP Lentivirus Production Industry Trends
2.3.2 cGMP Lentivirus Production Market Drivers
2.3.3 cGMP Lentivirus Production Market Challenges
2.3.4 cGMP Lentivirus Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Lentivirus Production Players by Revenue
3.1.1 Global Top cGMP Lentivirus Production Players by Revenue (2020-2025)
3.1.2 Global cGMP Lentivirus Production Revenue Market Share by Players (2020-2025)
3.2 Global cGMP Lentivirus Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by cGMP Lentivirus Production Revenue
3.4 Global cGMP Lentivirus Production Market Concentration Ratio
3.4.1 Global cGMP Lentivirus Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Lentivirus Production Revenue in 2024
3.5 Global Key Players of cGMP Lentivirus Production Head office and Area Served
3.6 Global Key Players of cGMP Lentivirus Production, Product and Application
3.7 Global Key Players of cGMP Lentivirus Production, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 cGMP Lentivirus Production Breakdown Data by Type
4.1 Global cGMP Lentivirus Production Historic Market Size by Type (2020-2025)
4.2 Global cGMP Lentivirus Production Forecasted Market Size by Type (2026-2031)
5 cGMP Lentivirus Production Breakdown Data by Application
5.1 Global cGMP Lentivirus Production Historic Market Size by Application (2020-2025)
5.2 Global cGMP Lentivirus Production Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America cGMP Lentivirus Production Market Size (2020-2031)
6.2 North America cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America cGMP Lentivirus Production Market Size by Country (2020-2025)
6.4 North America cGMP Lentivirus Production Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe cGMP Lentivirus Production Market Size (2020-2031)
7.2 Europe cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe cGMP Lentivirus Production Market Size by Country (2020-2025)
7.4 Europe cGMP Lentivirus Production Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific cGMP Lentivirus Production Market Size (2020-2031)
8.2 Asia-Pacific cGMP Lentivirus Production Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific cGMP Lentivirus Production Market Size by Region (2020-2025)
8.4 Asia-Pacific cGMP Lentivirus Production Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America cGMP Lentivirus Production Market Size (2020-2031)
9.2 Latin America cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America cGMP Lentivirus Production Market Size by Country (2020-2025)
9.4 Latin America cGMP Lentivirus Production Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Lentivirus Production Market Size (2020-2031)
10.2 Middle East & Africa cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa cGMP Lentivirus Production Market Size by Country (2020-2025)
10.4 Middle East & Africa cGMP Lentivirus Production Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific cGMP Lentivirus Production Introduction
11.1.4 Thermo Fisher Scientific Revenue in cGMP Lentivirus Production Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Oxgene
11.2.1 Oxgene Company Details
11.2.2 Oxgene Business Overview
11.2.3 Oxgene cGMP Lentivirus Production Introduction
11.2.4 Oxgene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.2.5 Oxgene Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza cGMP Lentivirus Production Introduction
11.3.4 Lonza Revenue in cGMP Lentivirus Production Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Charles River (Vigene Biosciences)
11.4.1 Charles River (Vigene Biosciences) Company Details
11.4.2 Charles River (Vigene Biosciences) Business Overview
11.4.3 Charles River (Vigene Biosciences) cGMP Lentivirus Production Introduction
11.4.4 Charles River (Vigene Biosciences) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.4.5 Charles River (Vigene Biosciences) Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck cGMP Lentivirus Production Introduction
11.5.4 Merck Revenue in cGMP Lentivirus Production Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Cytiva
11.6.1 Cytiva Company Details
11.6.2 Cytiva Business Overview
11.6.3 Cytiva cGMP Lentivirus Production Introduction
11.6.4 Cytiva Revenue in cGMP Lentivirus Production Business (2020-2025)
11.6.5 Cytiva Recent Development
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Details
11.7.2 Oxford Biomedica Business Overview
11.7.3 Oxford Biomedica cGMP Lentivirus Production Introduction
11.7.4 Oxford Biomedica Revenue in cGMP Lentivirus Production Business (2020-2025)
11.7.5 Oxford Biomedica Recent Development
11.8 AGC Biologics(MolMed)
11.8.1 AGC Biologics(MolMed) Company Details
11.8.2 AGC Biologics(MolMed) Business Overview
11.8.3 AGC Biologics(MolMed) cGMP Lentivirus Production Introduction
11.8.4 AGC Biologics(MolMed) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.8.5 AGC Biologics(MolMed) Recent Development
11.9 GeneMedi
11.9.1 GeneMedi Company Details
11.9.2 GeneMedi Business Overview
11.9.3 GeneMedi cGMP Lentivirus Production Introduction
11.9.4 GeneMedi Revenue in cGMP Lentivirus Production Business (2020-2025)
11.9.5 GeneMedi Recent Development
11.10 OriGene
11.10.1 OriGene Company Details
11.10.2 OriGene Business Overview
11.10.3 OriGene cGMP Lentivirus Production Introduction
11.10.4 OriGene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.10.5 OriGene Recent Development
11.11 Invitria
11.11.1 Invitria Company Details
11.11.2 Invitria Business Overview
11.11.3 Invitria cGMP Lentivirus Production Introduction
11.11.4 Invitria Revenue in cGMP Lentivirus Production Business (2020-2025)
11.11.5 Invitria Recent Development
11.12 Polyplus (Sartorius)
11.12.1 Polyplus (Sartorius) Company Details
11.12.2 Polyplus (Sartorius) Business Overview
11.12.3 Polyplus (Sartorius) cGMP Lentivirus Production Introduction
11.12.4 Polyplus (Sartorius) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.12.5 Polyplus (Sartorius) Recent Development
11.13 Kerafast
11.13.1 Kerafast Company Details
11.13.2 Kerafast Business Overview
11.13.3 Kerafast cGMP Lentivirus Production Introduction
11.13.4 Kerafast Revenue in cGMP Lentivirus Production Business (2020-2025)
11.13.5 Kerafast Recent Development
11.14 CCRM
11.14.1 CCRM Company Details
11.14.2 CCRM Business Overview
11.14.3 CCRM cGMP Lentivirus Production Introduction
11.14.4 CCRM Revenue in cGMP Lentivirus Production Business (2020-2025)
11.14.5 CCRM Recent Development
11.15 SignaGen Laboratories
11.15.1 SignaGen Laboratories Company Details
11.15.2 SignaGen Laboratories Business Overview
11.15.3 SignaGen Laboratories cGMP Lentivirus Production Introduction
11.15.4 SignaGen Laboratories Revenue in cGMP Lentivirus Production Business (2020-2025)
11.15.5 SignaGen Laboratories Recent Development
11.16 Cellomics Technology
11.16.1 Cellomics Technology Company Details
11.16.2 Cellomics Technology Business Overview
11.16.3 Cellomics Technology cGMP Lentivirus Production Introduction
11.16.4 Cellomics Technology Revenue in cGMP Lentivirus Production Business (2020-2025)
11.16.5 Cellomics Technology Recent Development
11.17 FUJIFILM Diosynth Biotechnologies
11.17.1 FUJIFILM Diosynth Biotechnologies Company Details
11.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.17.3 FUJIFILM Diosynth Biotechnologies cGMP Lentivirus Production Introduction
11.17.4 FUJIFILM Diosynth Biotechnologies Revenue in cGMP Lentivirus Production Business (2020-2025)
11.17.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.18 Biovian
11.18.1 Biovian Company Details
11.18.2 Biovian Business Overview
11.18.3 Biovian cGMP Lentivirus Production Introduction
11.18.4 Biovian Revenue in cGMP Lentivirus Production Business (2020-2025)
11.18.5 Biovian Recent Development
11.19 Miltenyi Bioindustry
11.19.1 Miltenyi Bioindustry Company Details
11.19.2 Miltenyi Bioindustry Business Overview
11.19.3 Miltenyi Bioindustry cGMP Lentivirus Production Introduction
11.19.4 Miltenyi Bioindustry Revenue in cGMP Lentivirus Production Business (2020-2025)
11.19.5 Miltenyi Bioindustry Recent Development
11.20 Gene Universal
11.20.1 Gene Universal Company Details
11.20.2 Gene Universal Business Overview
11.20.3 Gene Universal cGMP Lentivirus Production Introduction
11.20.4 Gene Universal Revenue in cGMP Lentivirus Production Business (2020-2025)
11.20.5 Gene Universal Recent Development
11.21 Aldevron
11.21.1 Aldevron Company Details
11.21.2 Aldevron Business Overview
11.21.3 Aldevron cGMP Lentivirus Production Introduction
11.21.4 Aldevron Revenue in cGMP Lentivirus Production Business (2020-2025)
11.21.5 Aldevron Recent Development
11.22 Takara Bio
11.22.1 Takara Bio Company Details
11.22.2 Takara Bio Business Overview
11.22.3 Takara Bio cGMP Lentivirus Production Introduction
11.22.4 Takara Bio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.22.5 Takara Bio Recent Development
11.23 Gentarget
11.23.1 Gentarget Company Details
11.23.2 Gentarget Business Overview
11.23.3 Gentarget cGMP Lentivirus Production Introduction
11.23.4 Gentarget Revenue in cGMP Lentivirus Production Business (2020-2025)
11.23.5 Gentarget Recent Development
11.24 Bluebird Bio
11.24.1 Bluebird Bio Company Details
11.24.2 Bluebird Bio Business Overview
11.24.3 Bluebird Bio cGMP Lentivirus Production Introduction
11.24.4 Bluebird Bio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.24.5 Bluebird Bio Recent Development
11.25 ElevateBio
11.25.1 ElevateBio Company Details
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio cGMP Lentivirus Production Introduction
11.25.4 ElevateBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.25.5 ElevateBio Recent Development
11.26 Genezen
11.26.1 Genezen Company Details
11.26.2 Genezen Business Overview
11.26.3 Genezen cGMP Lentivirus Production Introduction
11.26.4 Genezen Revenue in cGMP Lentivirus Production Business (2020-2025)
11.26.5 Genezen Recent Development
11.27 EurekaBio
11.27.1 EurekaBio Company Details
11.27.2 EurekaBio Business Overview
11.27.3 EurekaBio cGMP Lentivirus Production Introduction
11.27.4 EurekaBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.27.5 EurekaBio Recent Development
11.28 Obio Technology
11.28.1 Obio Technology Company Details
11.28.2 Obio Technology Business Overview
11.28.3 Obio Technology cGMP Lentivirus Production Introduction
11.28.4 Obio Technology Revenue in cGMP Lentivirus Production Business (2020-2025)
11.28.5 Obio Technology Recent Development
11.29 WuXi ATU
11.29.1 WuXi ATU Company Details
11.29.2 WuXi ATU Business Overview
11.29.3 WuXi ATU cGMP Lentivirus Production Introduction
11.29.4 WuXi ATU Revenue in cGMP Lentivirus Production Business (2020-2025)
11.29.5 WuXi ATU Recent Development
11.30 GenScript ProBio
11.30.1 GenScript ProBio Company Details
11.30.2 GenScript ProBio Business Overview
11.30.3 GenScript ProBio cGMP Lentivirus Production Introduction
11.30.4 GenScript ProBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.30.5 GenScript ProBio Recent Development
11.31 Creative Biogene
11.31.1 Creative Biogene Company Details
11.31.2 Creative Biogene Business Overview
11.31.3 Creative Biogene cGMP Lentivirus Production Introduction
11.31.4 Creative Biogene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.31.5 Creative Biogene Recent Development
11.32 VIVEbiotech
11.32.1 VIVEbiotech Company Details
11.32.2 VIVEbiotech Business Overview
11.32.3 VIVEbiotech cGMP Lentivirus Production Introduction
11.32.4 VIVEbiotech Revenue in cGMP Lentivirus Production Business (2020-2025)
11.32.5 VIVEbiotech Recent Development
11.33 Yposkesi (SK pharmteco)
11.33.1 Yposkesi (SK pharmteco) Company Details
11.33.2 Yposkesi (SK pharmteco) Business Overview
11.33.3 Yposkesi (SK pharmteco) cGMP Lentivirus Production Introduction
11.33.4 Yposkesi (SK pharmteco) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.33.5 Yposkesi (SK pharmteco) Recent Development
11.34 VectorBuilder
11.34.1 VectorBuilder Company Details
11.34.2 VectorBuilder Business Overview
11.34.3 VectorBuilder cGMP Lentivirus Production Introduction
11.34.4 VectorBuilder Revenue in cGMP Lentivirus Production Business (2020-2025)
11.34.5 VectorBuilder Recent Development
11.35 Esco Aster
11.35.1 Esco Aster Company Details
11.35.2 Esco Aster Business Overview
11.35.3 Esco Aster cGMP Lentivirus Production Introduction
11.35.4 Esco Aster Revenue in cGMP Lentivirus Production Business (2020-2025)
11.35.5 Esco Aster Recent Development
11.36 Andelyn Biosciences
11.36.1 Andelyn Biosciences Company Details
11.36.2 Andelyn Biosciences Business Overview
11.36.3 Andelyn Biosciences cGMP Lentivirus Production Introduction
11.36.4 Andelyn Biosciences Revenue in cGMP Lentivirus Production Business (2020-2025)
11.36.5 Andelyn Biosciences Recent Development
11.37 Single Use Support
11.37.1 Single Use Support Company Details
11.37.2 Single Use Support Business Overview
11.37.3 Single Use Support cGMP Lentivirus Production Introduction
11.37.4 Single Use Support Revenue in cGMP Lentivirus Production Business (2020-2025)
11.37.5 Single Use Support Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global cGMP Lentivirus Production Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adherent Culture
1.2.3 Suspension Culture
1.2.4 Others
1.3 Market by Application
1.3.1 Global cGMP Lentivirus Production Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 CDMO
1.3.3 Biotech
1.3.4 Pharma
1.3.5 Academia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global cGMP Lentivirus Production Market Perspective (2020-2031)
2.2 Global cGMP Lentivirus Production Growth Trends by Region
2.2.1 Global cGMP Lentivirus Production Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 cGMP Lentivirus Production Historic Market Size by Region (2020-2025)
2.2.3 cGMP Lentivirus Production Forecasted Market Size by Region (2026-2031)
2.3 cGMP Lentivirus Production Market Dynamics
2.3.1 cGMP Lentivirus Production Industry Trends
2.3.2 cGMP Lentivirus Production Market Drivers
2.3.3 cGMP Lentivirus Production Market Challenges
2.3.4 cGMP Lentivirus Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Lentivirus Production Players by Revenue
3.1.1 Global Top cGMP Lentivirus Production Players by Revenue (2020-2025)
3.1.2 Global cGMP Lentivirus Production Revenue Market Share by Players (2020-2025)
3.2 Global cGMP Lentivirus Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by cGMP Lentivirus Production Revenue
3.4 Global cGMP Lentivirus Production Market Concentration Ratio
3.4.1 Global cGMP Lentivirus Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Lentivirus Production Revenue in 2024
3.5 Global Key Players of cGMP Lentivirus Production Head office and Area Served
3.6 Global Key Players of cGMP Lentivirus Production, Product and Application
3.7 Global Key Players of cGMP Lentivirus Production, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 cGMP Lentivirus Production Breakdown Data by Type
4.1 Global cGMP Lentivirus Production Historic Market Size by Type (2020-2025)
4.2 Global cGMP Lentivirus Production Forecasted Market Size by Type (2026-2031)
5 cGMP Lentivirus Production Breakdown Data by Application
5.1 Global cGMP Lentivirus Production Historic Market Size by Application (2020-2025)
5.2 Global cGMP Lentivirus Production Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America cGMP Lentivirus Production Market Size (2020-2031)
6.2 North America cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America cGMP Lentivirus Production Market Size by Country (2020-2025)
6.4 North America cGMP Lentivirus Production Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe cGMP Lentivirus Production Market Size (2020-2031)
7.2 Europe cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe cGMP Lentivirus Production Market Size by Country (2020-2025)
7.4 Europe cGMP Lentivirus Production Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific cGMP Lentivirus Production Market Size (2020-2031)
8.2 Asia-Pacific cGMP Lentivirus Production Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific cGMP Lentivirus Production Market Size by Region (2020-2025)
8.4 Asia-Pacific cGMP Lentivirus Production Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America cGMP Lentivirus Production Market Size (2020-2031)
9.2 Latin America cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America cGMP Lentivirus Production Market Size by Country (2020-2025)
9.4 Latin America cGMP Lentivirus Production Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Lentivirus Production Market Size (2020-2031)
10.2 Middle East & Africa cGMP Lentivirus Production Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa cGMP Lentivirus Production Market Size by Country (2020-2025)
10.4 Middle East & Africa cGMP Lentivirus Production Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific cGMP Lentivirus Production Introduction
11.1.4 Thermo Fisher Scientific Revenue in cGMP Lentivirus Production Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Oxgene
11.2.1 Oxgene Company Details
11.2.2 Oxgene Business Overview
11.2.3 Oxgene cGMP Lentivirus Production Introduction
11.2.4 Oxgene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.2.5 Oxgene Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza cGMP Lentivirus Production Introduction
11.3.4 Lonza Revenue in cGMP Lentivirus Production Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Charles River (Vigene Biosciences)
11.4.1 Charles River (Vigene Biosciences) Company Details
11.4.2 Charles River (Vigene Biosciences) Business Overview
11.4.3 Charles River (Vigene Biosciences) cGMP Lentivirus Production Introduction
11.4.4 Charles River (Vigene Biosciences) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.4.5 Charles River (Vigene Biosciences) Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck cGMP Lentivirus Production Introduction
11.5.4 Merck Revenue in cGMP Lentivirus Production Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Cytiva
11.6.1 Cytiva Company Details
11.6.2 Cytiva Business Overview
11.6.3 Cytiva cGMP Lentivirus Production Introduction
11.6.4 Cytiva Revenue in cGMP Lentivirus Production Business (2020-2025)
11.6.5 Cytiva Recent Development
11.7 Oxford Biomedica
11.7.1 Oxford Biomedica Company Details
11.7.2 Oxford Biomedica Business Overview
11.7.3 Oxford Biomedica cGMP Lentivirus Production Introduction
11.7.4 Oxford Biomedica Revenue in cGMP Lentivirus Production Business (2020-2025)
11.7.5 Oxford Biomedica Recent Development
11.8 AGC Biologics(MolMed)
11.8.1 AGC Biologics(MolMed) Company Details
11.8.2 AGC Biologics(MolMed) Business Overview
11.8.3 AGC Biologics(MolMed) cGMP Lentivirus Production Introduction
11.8.4 AGC Biologics(MolMed) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.8.5 AGC Biologics(MolMed) Recent Development
11.9 GeneMedi
11.9.1 GeneMedi Company Details
11.9.2 GeneMedi Business Overview
11.9.3 GeneMedi cGMP Lentivirus Production Introduction
11.9.4 GeneMedi Revenue in cGMP Lentivirus Production Business (2020-2025)
11.9.5 GeneMedi Recent Development
11.10 OriGene
11.10.1 OriGene Company Details
11.10.2 OriGene Business Overview
11.10.3 OriGene cGMP Lentivirus Production Introduction
11.10.4 OriGene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.10.5 OriGene Recent Development
11.11 Invitria
11.11.1 Invitria Company Details
11.11.2 Invitria Business Overview
11.11.3 Invitria cGMP Lentivirus Production Introduction
11.11.4 Invitria Revenue in cGMP Lentivirus Production Business (2020-2025)
11.11.5 Invitria Recent Development
11.12 Polyplus (Sartorius)
11.12.1 Polyplus (Sartorius) Company Details
11.12.2 Polyplus (Sartorius) Business Overview
11.12.3 Polyplus (Sartorius) cGMP Lentivirus Production Introduction
11.12.4 Polyplus (Sartorius) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.12.5 Polyplus (Sartorius) Recent Development
11.13 Kerafast
11.13.1 Kerafast Company Details
11.13.2 Kerafast Business Overview
11.13.3 Kerafast cGMP Lentivirus Production Introduction
11.13.4 Kerafast Revenue in cGMP Lentivirus Production Business (2020-2025)
11.13.5 Kerafast Recent Development
11.14 CCRM
11.14.1 CCRM Company Details
11.14.2 CCRM Business Overview
11.14.3 CCRM cGMP Lentivirus Production Introduction
11.14.4 CCRM Revenue in cGMP Lentivirus Production Business (2020-2025)
11.14.5 CCRM Recent Development
11.15 SignaGen Laboratories
11.15.1 SignaGen Laboratories Company Details
11.15.2 SignaGen Laboratories Business Overview
11.15.3 SignaGen Laboratories cGMP Lentivirus Production Introduction
11.15.4 SignaGen Laboratories Revenue in cGMP Lentivirus Production Business (2020-2025)
11.15.5 SignaGen Laboratories Recent Development
11.16 Cellomics Technology
11.16.1 Cellomics Technology Company Details
11.16.2 Cellomics Technology Business Overview
11.16.3 Cellomics Technology cGMP Lentivirus Production Introduction
11.16.4 Cellomics Technology Revenue in cGMP Lentivirus Production Business (2020-2025)
11.16.5 Cellomics Technology Recent Development
11.17 FUJIFILM Diosynth Biotechnologies
11.17.1 FUJIFILM Diosynth Biotechnologies Company Details
11.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.17.3 FUJIFILM Diosynth Biotechnologies cGMP Lentivirus Production Introduction
11.17.4 FUJIFILM Diosynth Biotechnologies Revenue in cGMP Lentivirus Production Business (2020-2025)
11.17.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.18 Biovian
11.18.1 Biovian Company Details
11.18.2 Biovian Business Overview
11.18.3 Biovian cGMP Lentivirus Production Introduction
11.18.4 Biovian Revenue in cGMP Lentivirus Production Business (2020-2025)
11.18.5 Biovian Recent Development
11.19 Miltenyi Bioindustry
11.19.1 Miltenyi Bioindustry Company Details
11.19.2 Miltenyi Bioindustry Business Overview
11.19.3 Miltenyi Bioindustry cGMP Lentivirus Production Introduction
11.19.4 Miltenyi Bioindustry Revenue in cGMP Lentivirus Production Business (2020-2025)
11.19.5 Miltenyi Bioindustry Recent Development
11.20 Gene Universal
11.20.1 Gene Universal Company Details
11.20.2 Gene Universal Business Overview
11.20.3 Gene Universal cGMP Lentivirus Production Introduction
11.20.4 Gene Universal Revenue in cGMP Lentivirus Production Business (2020-2025)
11.20.5 Gene Universal Recent Development
11.21 Aldevron
11.21.1 Aldevron Company Details
11.21.2 Aldevron Business Overview
11.21.3 Aldevron cGMP Lentivirus Production Introduction
11.21.4 Aldevron Revenue in cGMP Lentivirus Production Business (2020-2025)
11.21.5 Aldevron Recent Development
11.22 Takara Bio
11.22.1 Takara Bio Company Details
11.22.2 Takara Bio Business Overview
11.22.3 Takara Bio cGMP Lentivirus Production Introduction
11.22.4 Takara Bio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.22.5 Takara Bio Recent Development
11.23 Gentarget
11.23.1 Gentarget Company Details
11.23.2 Gentarget Business Overview
11.23.3 Gentarget cGMP Lentivirus Production Introduction
11.23.4 Gentarget Revenue in cGMP Lentivirus Production Business (2020-2025)
11.23.5 Gentarget Recent Development
11.24 Bluebird Bio
11.24.1 Bluebird Bio Company Details
11.24.2 Bluebird Bio Business Overview
11.24.3 Bluebird Bio cGMP Lentivirus Production Introduction
11.24.4 Bluebird Bio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.24.5 Bluebird Bio Recent Development
11.25 ElevateBio
11.25.1 ElevateBio Company Details
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio cGMP Lentivirus Production Introduction
11.25.4 ElevateBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.25.5 ElevateBio Recent Development
11.26 Genezen
11.26.1 Genezen Company Details
11.26.2 Genezen Business Overview
11.26.3 Genezen cGMP Lentivirus Production Introduction
11.26.4 Genezen Revenue in cGMP Lentivirus Production Business (2020-2025)
11.26.5 Genezen Recent Development
11.27 EurekaBio
11.27.1 EurekaBio Company Details
11.27.2 EurekaBio Business Overview
11.27.3 EurekaBio cGMP Lentivirus Production Introduction
11.27.4 EurekaBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.27.5 EurekaBio Recent Development
11.28 Obio Technology
11.28.1 Obio Technology Company Details
11.28.2 Obio Technology Business Overview
11.28.3 Obio Technology cGMP Lentivirus Production Introduction
11.28.4 Obio Technology Revenue in cGMP Lentivirus Production Business (2020-2025)
11.28.5 Obio Technology Recent Development
11.29 WuXi ATU
11.29.1 WuXi ATU Company Details
11.29.2 WuXi ATU Business Overview
11.29.3 WuXi ATU cGMP Lentivirus Production Introduction
11.29.4 WuXi ATU Revenue in cGMP Lentivirus Production Business (2020-2025)
11.29.5 WuXi ATU Recent Development
11.30 GenScript ProBio
11.30.1 GenScript ProBio Company Details
11.30.2 GenScript ProBio Business Overview
11.30.3 GenScript ProBio cGMP Lentivirus Production Introduction
11.30.4 GenScript ProBio Revenue in cGMP Lentivirus Production Business (2020-2025)
11.30.5 GenScript ProBio Recent Development
11.31 Creative Biogene
11.31.1 Creative Biogene Company Details
11.31.2 Creative Biogene Business Overview
11.31.3 Creative Biogene cGMP Lentivirus Production Introduction
11.31.4 Creative Biogene Revenue in cGMP Lentivirus Production Business (2020-2025)
11.31.5 Creative Biogene Recent Development
11.32 VIVEbiotech
11.32.1 VIVEbiotech Company Details
11.32.2 VIVEbiotech Business Overview
11.32.3 VIVEbiotech cGMP Lentivirus Production Introduction
11.32.4 VIVEbiotech Revenue in cGMP Lentivirus Production Business (2020-2025)
11.32.5 VIVEbiotech Recent Development
11.33 Yposkesi (SK pharmteco)
11.33.1 Yposkesi (SK pharmteco) Company Details
11.33.2 Yposkesi (SK pharmteco) Business Overview
11.33.3 Yposkesi (SK pharmteco) cGMP Lentivirus Production Introduction
11.33.4 Yposkesi (SK pharmteco) Revenue in cGMP Lentivirus Production Business (2020-2025)
11.33.5 Yposkesi (SK pharmteco) Recent Development
11.34 VectorBuilder
11.34.1 VectorBuilder Company Details
11.34.2 VectorBuilder Business Overview
11.34.3 VectorBuilder cGMP Lentivirus Production Introduction
11.34.4 VectorBuilder Revenue in cGMP Lentivirus Production Business (2020-2025)
11.34.5 VectorBuilder Recent Development
11.35 Esco Aster
11.35.1 Esco Aster Company Details
11.35.2 Esco Aster Business Overview
11.35.3 Esco Aster cGMP Lentivirus Production Introduction
11.35.4 Esco Aster Revenue in cGMP Lentivirus Production Business (2020-2025)
11.35.5 Esco Aster Recent Development
11.36 Andelyn Biosciences
11.36.1 Andelyn Biosciences Company Details
11.36.2 Andelyn Biosciences Business Overview
11.36.3 Andelyn Biosciences cGMP Lentivirus Production Introduction
11.36.4 Andelyn Biosciences Revenue in cGMP Lentivirus Production Business (2020-2025)
11.36.5 Andelyn Biosciences Recent Development
11.37 Single Use Support
11.37.1 Single Use Support Company Details
11.37.2 Single Use Support Business Overview
11.37.3 Single Use Support cGMP Lentivirus Production Introduction
11.37.4 Single Use Support Revenue in cGMP Lentivirus Production Business (2020-2025)
11.37.5 Single Use Support Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global cGMP Lentivirus Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adherent Culture
Table 3. Key Players of Suspension Culture
Table 4. Key Players of Others
Table 5. Global cGMP Lentivirus Production Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global cGMP Lentivirus Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global cGMP Lentivirus Production Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global cGMP Lentivirus Production Market Share by Region (2020-2025)
Table 9. Global cGMP Lentivirus Production Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global cGMP Lentivirus Production Market Share by Region (2026-2031)
Table 11. cGMP Lentivirus Production Market Trends
Table 12. cGMP Lentivirus Production Market Drivers
Table 13. cGMP Lentivirus Production Market Challenges
Table 14. cGMP Lentivirus Production Market Restraints
Table 15. Global cGMP Lentivirus Production Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global cGMP Lentivirus Production Market Share by Players (2020-2025)
Table 17. Global Top cGMP Lentivirus Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in cGMP Lentivirus Production as of 2024)
Table 18. Ranking of Global Top cGMP Lentivirus Production Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by cGMP Lentivirus Production Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of cGMP Lentivirus Production, Headquarters and Area Served
Table 21. Global Key Players of cGMP Lentivirus Production, Product and Application
Table 22. Global Key Players of cGMP Lentivirus Production, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global cGMP Lentivirus Production Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global cGMP Lentivirus Production Revenue Market Share by Type (2020-2025)
Table 26. Global cGMP Lentivirus Production Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global cGMP Lentivirus Production Revenue Market Share by Type (2026-2031)
Table 28. Global cGMP Lentivirus Production Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global cGMP Lentivirus Production Revenue Market Share by Application (2020-2025)
Table 30. Global cGMP Lentivirus Production Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global cGMP Lentivirus Production Revenue Market Share by Application (2026-2031)
Table 32. North America cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific cGMP Lentivirus Production Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific cGMP Lentivirus Production Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific cGMP Lentivirus Production Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific cGMP Lentivirus Production Product
Table 50. Thermo Fisher Scientific Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Oxgene Company Details
Table 53. Oxgene Business Overview
Table 54. Oxgene cGMP Lentivirus Production Product
Table 55. Oxgene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 56. Oxgene Recent Development
Table 57. Lonza Company Details
Table 58. Lonza Business Overview
Table 59. Lonza cGMP Lentivirus Production Product
Table 60. Lonza Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Charles River (Vigene Biosciences) Company Details
Table 63. Charles River (Vigene Biosciences) Business Overview
Table 64. Charles River (Vigene Biosciences) cGMP Lentivirus Production Product
Table 65. Charles River (Vigene Biosciences) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 66. Charles River (Vigene Biosciences) Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck cGMP Lentivirus Production Product
Table 70. Merck Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Cytiva Company Details
Table 73. Cytiva Business Overview
Table 74. Cytiva cGMP Lentivirus Production Product
Table 75. Cytiva Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 76. Cytiva Recent Development
Table 77. Oxford Biomedica Company Details
Table 78. Oxford Biomedica Business Overview
Table 79. Oxford Biomedica cGMP Lentivirus Production Product
Table 80. Oxford Biomedica Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 81. Oxford Biomedica Recent Development
Table 82. AGC Biologics(MolMed) Company Details
Table 83. AGC Biologics(MolMed) Business Overview
Table 84. AGC Biologics(MolMed) cGMP Lentivirus Production Product
Table 85. AGC Biologics(MolMed) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 86. AGC Biologics(MolMed) Recent Development
Table 87. GeneMedi Company Details
Table 88. GeneMedi Business Overview
Table 89. GeneMedi cGMP Lentivirus Production Product
Table 90. GeneMedi Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 91. GeneMedi Recent Development
Table 92. OriGene Company Details
Table 93. OriGene Business Overview
Table 94. OriGene cGMP Lentivirus Production Product
Table 95. OriGene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 96. OriGene Recent Development
Table 97. Invitria Company Details
Table 98. Invitria Business Overview
Table 99. Invitria cGMP Lentivirus Production Product
Table 100. Invitria Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 101. Invitria Recent Development
Table 102. Polyplus (Sartorius) Company Details
Table 103. Polyplus (Sartorius) Business Overview
Table 104. Polyplus (Sartorius) cGMP Lentivirus Production Product
Table 105. Polyplus (Sartorius) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 106. Polyplus (Sartorius) Recent Development
Table 107. Kerafast Company Details
Table 108. Kerafast Business Overview
Table 109. Kerafast cGMP Lentivirus Production Product
Table 110. Kerafast Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 111. Kerafast Recent Development
Table 112. CCRM Company Details
Table 113. CCRM Business Overview
Table 114. CCRM cGMP Lentivirus Production Product
Table 115. CCRM Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 116. CCRM Recent Development
Table 117. SignaGen Laboratories Company Details
Table 118. SignaGen Laboratories Business Overview
Table 119. SignaGen Laboratories cGMP Lentivirus Production Product
Table 120. SignaGen Laboratories Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 121. SignaGen Laboratories Recent Development
Table 122. Cellomics Technology Company Details
Table 123. Cellomics Technology Business Overview
Table 124. Cellomics Technology cGMP Lentivirus Production Product
Table 125. Cellomics Technology Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 126. Cellomics Technology Recent Development
Table 127. FUJIFILM Diosynth Biotechnologies Company Details
Table 128. FUJIFILM Diosynth Biotechnologies Business Overview
Table 129. FUJIFILM Diosynth Biotechnologies cGMP Lentivirus Production Product
Table 130. FUJIFILM Diosynth Biotechnologies Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 131. FUJIFILM Diosynth Biotechnologies Recent Development
Table 132. Biovian Company Details
Table 133. Biovian Business Overview
Table 134. Biovian cGMP Lentivirus Production Product
Table 135. Biovian Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 136. Biovian Recent Development
Table 137. Miltenyi Bioindustry Company Details
Table 138. Miltenyi Bioindustry Business Overview
Table 139. Miltenyi Bioindustry cGMP Lentivirus Production Product
Table 140. Miltenyi Bioindustry Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 141. Miltenyi Bioindustry Recent Development
Table 142. Gene Universal Company Details
Table 143. Gene Universal Business Overview
Table 144. Gene Universal cGMP Lentivirus Production Product
Table 145. Gene Universal Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 146. Gene Universal Recent Development
Table 147. Aldevron Company Details
Table 148. Aldevron Business Overview
Table 149. Aldevron cGMP Lentivirus Production Product
Table 150. Aldevron Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 151. Aldevron Recent Development
Table 152. Takara Bio Company Details
Table 153. Takara Bio Business Overview
Table 154. Takara Bio cGMP Lentivirus Production Product
Table 155. Takara Bio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 156. Takara Bio Recent Development
Table 157. Gentarget Company Details
Table 158. Gentarget Business Overview
Table 159. Gentarget cGMP Lentivirus Production Product
Table 160. Gentarget Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 161. Gentarget Recent Development
Table 162. Bluebird Bio Company Details
Table 163. Bluebird Bio Business Overview
Table 164. Bluebird Bio cGMP Lentivirus Production Product
Table 165. Bluebird Bio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 166. Bluebird Bio Recent Development
Table 167. ElevateBio Company Details
Table 168. ElevateBio Business Overview
Table 169. ElevateBio cGMP Lentivirus Production Product
Table 170. ElevateBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 171. ElevateBio Recent Development
Table 172. Genezen Company Details
Table 173. Genezen Business Overview
Table 174. Genezen cGMP Lentivirus Production Product
Table 175. Genezen Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 176. Genezen Recent Development
Table 177. EurekaBio Company Details
Table 178. EurekaBio Business Overview
Table 179. EurekaBio cGMP Lentivirus Production Product
Table 180. EurekaBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 181. EurekaBio Recent Development
Table 182. Obio Technology Company Details
Table 183. Obio Technology Business Overview
Table 184. Obio Technology cGMP Lentivirus Production Product
Table 185. Obio Technology Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 186. Obio Technology Recent Development
Table 187. WuXi ATU Company Details
Table 188. WuXi ATU Business Overview
Table 189. WuXi ATU cGMP Lentivirus Production Product
Table 190. WuXi ATU Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 191. WuXi ATU Recent Development
Table 192. GenScript ProBio Company Details
Table 193. GenScript ProBio Business Overview
Table 194. GenScript ProBio cGMP Lentivirus Production Product
Table 195. GenScript ProBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 196. GenScript ProBio Recent Development
Table 197. Creative Biogene Company Details
Table 198. Creative Biogene Business Overview
Table 199. Creative Biogene cGMP Lentivirus Production Product
Table 200. Creative Biogene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 201. Creative Biogene Recent Development
Table 202. VIVEbiotech Company Details
Table 203. VIVEbiotech Business Overview
Table 204. VIVEbiotech cGMP Lentivirus Production Product
Table 205. VIVEbiotech Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 206. VIVEbiotech Recent Development
Table 207. Yposkesi (SK pharmteco) Company Details
Table 208. Yposkesi (SK pharmteco) Business Overview
Table 209. Yposkesi (SK pharmteco) cGMP Lentivirus Production Product
Table 210. Yposkesi (SK pharmteco) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 211. Yposkesi (SK pharmteco) Recent Development
Table 212. VectorBuilder Company Details
Table 213. VectorBuilder Business Overview
Table 214. VectorBuilder cGMP Lentivirus Production Product
Table 215. VectorBuilder Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 216. VectorBuilder Recent Development
Table 217. Esco Aster Company Details
Table 218. Esco Aster Business Overview
Table 219. Esco Aster cGMP Lentivirus Production Product
Table 220. Esco Aster Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 221. Esco Aster Recent Development
Table 222. Andelyn Biosciences Company Details
Table 223. Andelyn Biosciences Business Overview
Table 224. Andelyn Biosciences cGMP Lentivirus Production Product
Table 225. Andelyn Biosciences Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 226. Andelyn Biosciences Recent Development
Table 227. Single Use Support Company Details
Table 228. Single Use Support Business Overview
Table 229. Single Use Support cGMP Lentivirus Production Product
Table 230. Single Use Support Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 231. Single Use Support Recent Development
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
Table 235. Authors List of This Report
List of Figures
Figure 1. cGMP Lentivirus Production Picture
Figure 2. Global cGMP Lentivirus Production Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global cGMP Lentivirus Production Market Share by Type: 2024 VS 2031
Figure 4. Adherent Culture Features
Figure 5. Suspension Culture Features
Figure 6. Others Features
Figure 7. Global cGMP Lentivirus Production Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global cGMP Lentivirus Production Market Share by Application: 2024 VS 2031
Figure 9. CDMO Case Studies
Figure 10. Biotech Case Studies
Figure 11. Pharma Case Studies
Figure 12. Academia Case Studies
Figure 13. Others Case Studies
Figure 14. cGMP Lentivirus Production Report Years Considered
Figure 15. Global cGMP Lentivirus Production Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global cGMP Lentivirus Production Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global cGMP Lentivirus Production Market Share by Region: 2024 VS 2031
Figure 18. Global cGMP Lentivirus Production Market Share by Players in 2024
Figure 19. Global Top cGMP Lentivirus Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in cGMP Lentivirus Production as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by cGMP Lentivirus Production Revenue in 2024
Figure 21. North America cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 23. United States cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 27. Germany cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific cGMP Lentivirus Production Market Share by Region (2020-2031)
Figure 35. China cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 43. Mexico cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 47. Turkey cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 51. Oxgene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 53. Charles River (Vigene Biosciences) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 55. Cytiva Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 56. Oxford Biomedica Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 57. AGC Biologics(MolMed) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 58. GeneMedi Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 59. OriGene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 60. Invitria Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 61. Polyplus (Sartorius) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 62. Kerafast Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 63. CCRM Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 64. SignaGen Laboratories Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 65. Cellomics Technology Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 66. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 67. Biovian Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 68. Miltenyi Bioindustry Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 69. Gene Universal Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 70. Aldevron Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 71. Takara Bio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 72. Gentarget Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 73. Bluebird Bio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 74. ElevateBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 75. Genezen Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 76. EurekaBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 77. Obio Technology Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 78. WuXi ATU Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 79. GenScript ProBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 80. Creative Biogene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 81. VIVEbiotech Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 82. Yposkesi (SK pharmteco) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 83. VectorBuilder Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 84. Esco Aster Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 85. Andelyn Biosciences Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 86. Single Use Support Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Table 1. Global cGMP Lentivirus Production Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Adherent Culture
Table 3. Key Players of Suspension Culture
Table 4. Key Players of Others
Table 5. Global cGMP Lentivirus Production Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global cGMP Lentivirus Production Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global cGMP Lentivirus Production Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global cGMP Lentivirus Production Market Share by Region (2020-2025)
Table 9. Global cGMP Lentivirus Production Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global cGMP Lentivirus Production Market Share by Region (2026-2031)
Table 11. cGMP Lentivirus Production Market Trends
Table 12. cGMP Lentivirus Production Market Drivers
Table 13. cGMP Lentivirus Production Market Challenges
Table 14. cGMP Lentivirus Production Market Restraints
Table 15. Global cGMP Lentivirus Production Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global cGMP Lentivirus Production Market Share by Players (2020-2025)
Table 17. Global Top cGMP Lentivirus Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in cGMP Lentivirus Production as of 2024)
Table 18. Ranking of Global Top cGMP Lentivirus Production Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by cGMP Lentivirus Production Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of cGMP Lentivirus Production, Headquarters and Area Served
Table 21. Global Key Players of cGMP Lentivirus Production, Product and Application
Table 22. Global Key Players of cGMP Lentivirus Production, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global cGMP Lentivirus Production Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global cGMP Lentivirus Production Revenue Market Share by Type (2020-2025)
Table 26. Global cGMP Lentivirus Production Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global cGMP Lentivirus Production Revenue Market Share by Type (2026-2031)
Table 28. Global cGMP Lentivirus Production Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global cGMP Lentivirus Production Revenue Market Share by Application (2020-2025)
Table 30. Global cGMP Lentivirus Production Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global cGMP Lentivirus Production Revenue Market Share by Application (2026-2031)
Table 32. North America cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific cGMP Lentivirus Production Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific cGMP Lentivirus Production Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific cGMP Lentivirus Production Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa cGMP Lentivirus Production Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa cGMP Lentivirus Production Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa cGMP Lentivirus Production Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific cGMP Lentivirus Production Product
Table 50. Thermo Fisher Scientific Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Oxgene Company Details
Table 53. Oxgene Business Overview
Table 54. Oxgene cGMP Lentivirus Production Product
Table 55. Oxgene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 56. Oxgene Recent Development
Table 57. Lonza Company Details
Table 58. Lonza Business Overview
Table 59. Lonza cGMP Lentivirus Production Product
Table 60. Lonza Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Charles River (Vigene Biosciences) Company Details
Table 63. Charles River (Vigene Biosciences) Business Overview
Table 64. Charles River (Vigene Biosciences) cGMP Lentivirus Production Product
Table 65. Charles River (Vigene Biosciences) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 66. Charles River (Vigene Biosciences) Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck cGMP Lentivirus Production Product
Table 70. Merck Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Cytiva Company Details
Table 73. Cytiva Business Overview
Table 74. Cytiva cGMP Lentivirus Production Product
Table 75. Cytiva Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 76. Cytiva Recent Development
Table 77. Oxford Biomedica Company Details
Table 78. Oxford Biomedica Business Overview
Table 79. Oxford Biomedica cGMP Lentivirus Production Product
Table 80. Oxford Biomedica Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 81. Oxford Biomedica Recent Development
Table 82. AGC Biologics(MolMed) Company Details
Table 83. AGC Biologics(MolMed) Business Overview
Table 84. AGC Biologics(MolMed) cGMP Lentivirus Production Product
Table 85. AGC Biologics(MolMed) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 86. AGC Biologics(MolMed) Recent Development
Table 87. GeneMedi Company Details
Table 88. GeneMedi Business Overview
Table 89. GeneMedi cGMP Lentivirus Production Product
Table 90. GeneMedi Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 91. GeneMedi Recent Development
Table 92. OriGene Company Details
Table 93. OriGene Business Overview
Table 94. OriGene cGMP Lentivirus Production Product
Table 95. OriGene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 96. OriGene Recent Development
Table 97. Invitria Company Details
Table 98. Invitria Business Overview
Table 99. Invitria cGMP Lentivirus Production Product
Table 100. Invitria Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 101. Invitria Recent Development
Table 102. Polyplus (Sartorius) Company Details
Table 103. Polyplus (Sartorius) Business Overview
Table 104. Polyplus (Sartorius) cGMP Lentivirus Production Product
Table 105. Polyplus (Sartorius) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 106. Polyplus (Sartorius) Recent Development
Table 107. Kerafast Company Details
Table 108. Kerafast Business Overview
Table 109. Kerafast cGMP Lentivirus Production Product
Table 110. Kerafast Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 111. Kerafast Recent Development
Table 112. CCRM Company Details
Table 113. CCRM Business Overview
Table 114. CCRM cGMP Lentivirus Production Product
Table 115. CCRM Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 116. CCRM Recent Development
Table 117. SignaGen Laboratories Company Details
Table 118. SignaGen Laboratories Business Overview
Table 119. SignaGen Laboratories cGMP Lentivirus Production Product
Table 120. SignaGen Laboratories Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 121. SignaGen Laboratories Recent Development
Table 122. Cellomics Technology Company Details
Table 123. Cellomics Technology Business Overview
Table 124. Cellomics Technology cGMP Lentivirus Production Product
Table 125. Cellomics Technology Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 126. Cellomics Technology Recent Development
Table 127. FUJIFILM Diosynth Biotechnologies Company Details
Table 128. FUJIFILM Diosynth Biotechnologies Business Overview
Table 129. FUJIFILM Diosynth Biotechnologies cGMP Lentivirus Production Product
Table 130. FUJIFILM Diosynth Biotechnologies Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 131. FUJIFILM Diosynth Biotechnologies Recent Development
Table 132. Biovian Company Details
Table 133. Biovian Business Overview
Table 134. Biovian cGMP Lentivirus Production Product
Table 135. Biovian Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 136. Biovian Recent Development
Table 137. Miltenyi Bioindustry Company Details
Table 138. Miltenyi Bioindustry Business Overview
Table 139. Miltenyi Bioindustry cGMP Lentivirus Production Product
Table 140. Miltenyi Bioindustry Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 141. Miltenyi Bioindustry Recent Development
Table 142. Gene Universal Company Details
Table 143. Gene Universal Business Overview
Table 144. Gene Universal cGMP Lentivirus Production Product
Table 145. Gene Universal Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 146. Gene Universal Recent Development
Table 147. Aldevron Company Details
Table 148. Aldevron Business Overview
Table 149. Aldevron cGMP Lentivirus Production Product
Table 150. Aldevron Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 151. Aldevron Recent Development
Table 152. Takara Bio Company Details
Table 153. Takara Bio Business Overview
Table 154. Takara Bio cGMP Lentivirus Production Product
Table 155. Takara Bio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 156. Takara Bio Recent Development
Table 157. Gentarget Company Details
Table 158. Gentarget Business Overview
Table 159. Gentarget cGMP Lentivirus Production Product
Table 160. Gentarget Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 161. Gentarget Recent Development
Table 162. Bluebird Bio Company Details
Table 163. Bluebird Bio Business Overview
Table 164. Bluebird Bio cGMP Lentivirus Production Product
Table 165. Bluebird Bio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 166. Bluebird Bio Recent Development
Table 167. ElevateBio Company Details
Table 168. ElevateBio Business Overview
Table 169. ElevateBio cGMP Lentivirus Production Product
Table 170. ElevateBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 171. ElevateBio Recent Development
Table 172. Genezen Company Details
Table 173. Genezen Business Overview
Table 174. Genezen cGMP Lentivirus Production Product
Table 175. Genezen Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 176. Genezen Recent Development
Table 177. EurekaBio Company Details
Table 178. EurekaBio Business Overview
Table 179. EurekaBio cGMP Lentivirus Production Product
Table 180. EurekaBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 181. EurekaBio Recent Development
Table 182. Obio Technology Company Details
Table 183. Obio Technology Business Overview
Table 184. Obio Technology cGMP Lentivirus Production Product
Table 185. Obio Technology Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 186. Obio Technology Recent Development
Table 187. WuXi ATU Company Details
Table 188. WuXi ATU Business Overview
Table 189. WuXi ATU cGMP Lentivirus Production Product
Table 190. WuXi ATU Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 191. WuXi ATU Recent Development
Table 192. GenScript ProBio Company Details
Table 193. GenScript ProBio Business Overview
Table 194. GenScript ProBio cGMP Lentivirus Production Product
Table 195. GenScript ProBio Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 196. GenScript ProBio Recent Development
Table 197. Creative Biogene Company Details
Table 198. Creative Biogene Business Overview
Table 199. Creative Biogene cGMP Lentivirus Production Product
Table 200. Creative Biogene Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 201. Creative Biogene Recent Development
Table 202. VIVEbiotech Company Details
Table 203. VIVEbiotech Business Overview
Table 204. VIVEbiotech cGMP Lentivirus Production Product
Table 205. VIVEbiotech Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 206. VIVEbiotech Recent Development
Table 207. Yposkesi (SK pharmteco) Company Details
Table 208. Yposkesi (SK pharmteco) Business Overview
Table 209. Yposkesi (SK pharmteco) cGMP Lentivirus Production Product
Table 210. Yposkesi (SK pharmteco) Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 211. Yposkesi (SK pharmteco) Recent Development
Table 212. VectorBuilder Company Details
Table 213. VectorBuilder Business Overview
Table 214. VectorBuilder cGMP Lentivirus Production Product
Table 215. VectorBuilder Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 216. VectorBuilder Recent Development
Table 217. Esco Aster Company Details
Table 218. Esco Aster Business Overview
Table 219. Esco Aster cGMP Lentivirus Production Product
Table 220. Esco Aster Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 221. Esco Aster Recent Development
Table 222. Andelyn Biosciences Company Details
Table 223. Andelyn Biosciences Business Overview
Table 224. Andelyn Biosciences cGMP Lentivirus Production Product
Table 225. Andelyn Biosciences Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 226. Andelyn Biosciences Recent Development
Table 227. Single Use Support Company Details
Table 228. Single Use Support Business Overview
Table 229. Single Use Support cGMP Lentivirus Production Product
Table 230. Single Use Support Revenue in cGMP Lentivirus Production Business (2020-2025) & (US$ Million)
Table 231. Single Use Support Recent Development
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
Table 235. Authors List of This Report
List of Figures
Figure 1. cGMP Lentivirus Production Picture
Figure 2. Global cGMP Lentivirus Production Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global cGMP Lentivirus Production Market Share by Type: 2024 VS 2031
Figure 4. Adherent Culture Features
Figure 5. Suspension Culture Features
Figure 6. Others Features
Figure 7. Global cGMP Lentivirus Production Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global cGMP Lentivirus Production Market Share by Application: 2024 VS 2031
Figure 9. CDMO Case Studies
Figure 10. Biotech Case Studies
Figure 11. Pharma Case Studies
Figure 12. Academia Case Studies
Figure 13. Others Case Studies
Figure 14. cGMP Lentivirus Production Report Years Considered
Figure 15. Global cGMP Lentivirus Production Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global cGMP Lentivirus Production Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global cGMP Lentivirus Production Market Share by Region: 2024 VS 2031
Figure 18. Global cGMP Lentivirus Production Market Share by Players in 2024
Figure 19. Global Top cGMP Lentivirus Production Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in cGMP Lentivirus Production as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by cGMP Lentivirus Production Revenue in 2024
Figure 21. North America cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 23. United States cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 27. Germany cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific cGMP Lentivirus Production Market Share by Region (2020-2031)
Figure 35. China cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 43. Mexico cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa cGMP Lentivirus Production Market Share by Country (2020-2031)
Figure 47. Turkey cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE cGMP Lentivirus Production Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 51. Oxgene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 52. Lonza Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 53. Charles River (Vigene Biosciences) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 55. Cytiva Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 56. Oxford Biomedica Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 57. AGC Biologics(MolMed) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 58. GeneMedi Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 59. OriGene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 60. Invitria Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 61. Polyplus (Sartorius) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 62. Kerafast Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 63. CCRM Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 64. SignaGen Laboratories Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 65. Cellomics Technology Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 66. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 67. Biovian Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 68. Miltenyi Bioindustry Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 69. Gene Universal Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 70. Aldevron Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 71. Takara Bio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 72. Gentarget Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 73. Bluebird Bio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 74. ElevateBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 75. Genezen Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 76. EurekaBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 77. Obio Technology Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 78. WuXi ATU Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 79. GenScript ProBio Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 80. Creative Biogene Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 81. VIVEbiotech Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 82. Yposkesi (SK pharmteco) Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 83. VectorBuilder Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 84. Esco Aster Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 85. Andelyn Biosciences Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 86. Single Use Support Revenue Growth Rate in cGMP Lentivirus Production Business (2020-2025)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232